Experience the benefits of FDA-approved GLP-1 treatments and achieve your goals with professional guidance
Last reviewed: June 18, 2026 Last updated: June 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Only the very rare individual who is overly sensitive to the medicine is likely to reach this point while remaining within normal dosing
Even if GLP-1 medications slightly increased medullary thyroid cancer risk, the baseline rate is so low that the absolute risk would remain minimal
Here, we report that dual blockade can also prevent muscle loss associated with glucagon-like peptide-1 receptor agonists and even increase muscle mass in both obese mice and non-human primates
With a history of substance abuse Semaglutide